相关实验视频
Updated: Jun 9, 2025

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
甘氨酸载体1抑制剂将对吗啡的止痛耐受性降至最低
Anna Rita Galambos1,2, Nariman Essmat1,2, Péter P Lakatos2,3
1Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Nagyvárad tér 4, H-1085 Budapest, Hungary.
甘氨酸载体1 (GlyT-1) 抑制剂可能通过影响N-甲基D-酸盐受体 (NMDARs) 来延缓阿片类止痛药耐受性 (OAT),为慢性疼痛管理提供了一种新的策略.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
背景情况:
- 阿片类止痛药耐受性 (OAT) 限制了阿片类药物对慢性疼痛的长期有效性.
- 超突触N-甲基D-酸盐受体 (NMDARs) 和谷氨酸信号传递与OAT有关.
- 甘氨酸载体 (GlyTs),特别是GlyT-1,调节NMDAR的活性.
研究的目的:
- 研究GlyT-1抑制剂在预防或延迟阿片类止痛药耐受性方面的潜力.
- 探索涉及NMDAR途径的潜在机制.
主要方法:
- 在老鼠模型中,慢性皮下注射吗啡和GlyT-1抑制剂 (NFPS).
- 使用尾部测试来评估吗啡抗受体耐受性 (MAT).
- 对阿片类受体激活,蛋白质和mRNA表达的脊髓组织的分析.
- 在脑脊液中测量甘氨酸和谷氨酸水平.
主要成果:
- 同时服用吗啡和NFPS可降低大鼠的MAT.
- 单独或与吗啡一起的NFPS治疗改变了μ-阿片类受体的激活和脊髓组织中的表达,而不影响GluN2B mRNA.
- 脑脊髓液分析显示,甘氨酸和谷氨酸水平增加.
结论:
- GlyT-1 抑制剂在延缓吗啡抗受体耐受性 (MAT) 中表现有前途.
- 这种机制似乎涉及对NMDAR功能的调节,而不是增强阿片类药物的疗效.
- 这项研究为GlyT-1抑制剂对阿片类药物耐受性的影响提供了新的见解.
更多相关视频
07:23Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
05:24In Vivo SiRNA Transfection and Gene Knockdown in Spinal Cord via Rapid Noninvasive Lumbar Intrathecal Injections in Mice
Published on: March 22, 2014
相关概念视频
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Drugs Affecting Neurotransmitter Release or Uptake